Clinical Performance of Fiber Reinforced FRC Base and Bonded CAD/CAM Resin Composite Endocrowns

Clinical Performance of Fiber Reinforced FRC Base and Bonded CAD/CAM Resin Composite Endocrowns Versus Conventional Lithium Disilicate Endocrowns in Posterior Teeth (1y Randomized Clinical Trial)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06348979

Enrollment

110

Registered

2024-04-05

Start date

2022-01-01

Completion date

2024-01-30

Last updated

2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Keywords

restoration fracture, CAD/CAM resin composite endocrowns, lithium disilicate endocrowns

Brief summary

This research proposal is introduced to clinically test short fiber reinforced flowable resin composite material (everX Flow, GC Europe) as a supporting base under CAD/CAM resin composite endocrowns due to gap of knowledge present in this area.

Interventions

PROCEDUREFiber flowable (SFRC) support below hybrid nanoceramic endocrowns

restoration of endodontically treated teeth by endocrowns

PROCEDUREall ceramic Endocrowns (emax)

restoration of endodontically treated teeth by endocrowns

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 38 Years

Healthy volunteers

Yes

Inclusion criteria

* Endodontically treated molar teeth indicated for endocrown. * Presence of favorable occlusion and teeth are in normal alignment with the adjacent teeth, -medically free

Exclusion criteria

* ▪ Endodontically treated molar teeth indicated for post and core or only crown coverage. * Severe periodontal problems

Design outcomes

Primary

Measure	Time frame	Description
clinical Fracture	change from baseline and months: 3, 6, 12	modified usphs criteria (alpha, bravo, charlie) with measuring unit: scoring system (ordinal)

Secondary

Measure	Time frame	Description
clinical performance marginal adaptation	change from baseline and months: 3, 6, 12	modified usphs criteria (alpha, bravo, charlie) with measuring unit:scoring system (ordinal)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026